The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of breast cancer in men with exposure to 5-α reductase inhibitors: A RADAR report.
Steven M Belknap
No relevant relationships to disclose
Victoria Godinez-Puig
No relevant relationships to disclose
Robert E Brannigan
No relevant relationships to disclose
Simon M Lin
No relevant relationships to disclose
John Cashy
No relevant relationships to disclose
Rajesh Chowdhary
No relevant relationships to disclose
Michael J Postelnick
No relevant relationships to disclose
Michael A Fotis
No relevant relationships to disclose
Michael Irwig
No relevant relationships to disclose
Seema Ahsan Khan
No relevant relationships to disclose
William John Gradishar
No relevant relationships to disclose
Vishvas Garg
No relevant relationships to disclose
Xian Shen
No relevant relationships to disclose
Dennis W Raisch
No relevant relationships to disclose
Beatrice Nardone
No relevant relationships to disclose
Steven T. Rosen
No relevant relationships to disclose
Beatrice J. Edwards
Consultant or Advisory Role - Amgen; Lilly; Warner Chilcott
Honoraria - Amgen; Lilly; Warner Chilcott
June M McKoy
No relevant relationships to disclose
Paul R Yarnold
No relevant relationships to disclose
Dennis P. West
No relevant relationships to disclose